PTK787/ZK 222584
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PTK787/ZK 222584, covering 2013-10-21 to 2017-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584 [Phase 2]